Cindy Rose, Microsoft's chief operating officer for global enterprise sales, is leaving the tech behemoth to become CEO ...

Absci Corporation (NASDAQ:ABSI) is among the fundamentally strong penny stocks to invest in. Morgan Stanley has assumed ...

Former Abbott executive who led the US launch and global expansion of Humira® adds three decades of commercial and clinical leadership expertiseVANCOUVER, Wash., July 07, 2025 (GLOBE NEWSWIRE) -- ...

Absci Co. (NASDAQ:ABSI – Get Free Report) has received an average recommendation of “Buy” from the five ratings firms that are covering the company, Marketbeat.com reports. Five investment ...

People in Business Absci recently announced the appointment of veteran biopharmaceutical executive Mary Szela to its board of directors. With decades of research and development and commercial lea ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AbSci (ABSI – Research Report) and Sanofi (SNYNF – Research Report) with bulli ...

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-based drug for cancer ...

Find the latest information on Absci Corporation Common Stock (ABSI) insider activity and insider shares traded to make sound investments with Nasdaq.com.

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech ...